Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits
暂无分享,去创建一个
S D Thompson | D. Glass | S. Thompson | D N Glass | J. Phelan | J D Phelan | David N. Glass | James D. Phelan
[1] J. Tuomilehto,et al. Finnish case–control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis , 2005, Genes and Immunity.
[2] Elizabeth W Karlson,et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. , 2005, American journal of human genetics.
[3] Steven J. Schrodi,et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. , 2005, American journal of human genetics.
[4] B. Franke,et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. , 2005, Arthritis and rheumatism.
[5] F. Nicoletti,et al. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. , 2005, Endocrinology.
[6] Wendy Thomson,et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.
[7] H. Shimizu,et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata , 2005, Genes and Immunity.
[8] K. Pfeffer,et al. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games , 2005, Immunology.
[9] K. Boberg,et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases , 2005, Genes and Immunity.
[10] P. Gregersen. Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond , 2005, Immunological reviews.
[11] S. Gough,et al. CTLA4 gene polymorphism and autoimmunity , 2005, Immunological reviews.
[12] Annette Lee,et al. Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .
[13] V. Pascual,et al. Cross-regulation of TNF and IFN-¿ in autoimmune diseases , 2005 .
[14] J. Tuomilehto,et al. Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families. , 2005, Arthritis and rheumatism.
[15] V. Pascual,et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. Held,et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? , 2004, Clinical chemistry.
[17] Sampath Prahalad,et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. , 2004, Arthritis and rheumatism.
[18] Y. Matsui,et al. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. , 2004, Journal of molecular and cellular cardiology.
[19] A. Vicente,et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus , 2004, European Journal of Human Genetics.
[20] Steven J. Schrodi,et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.
[21] D. Glass,et al. Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. , 2004, Arthritis and rheumatism.
[22] E. Zeggini,et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.
[23] S. Giannouli,et al. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression , 2004, Annals of the Rheumatic Diseases.
[24] Nunzio Bottini,et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.
[25] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[26] L. Diehl,et al. PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells , 2004, Science.
[27] M. Simmonds,et al. Genetic insights into disease mechanisms of autoimmunity. , 2004, British medical bulletin.
[28] T. Hibi,et al. Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis , 2004, Journal of Gastroenterology.
[29] J. Epplen,et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis , 2004, BMC Genetics.
[30] S. Fisher,et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. , 2003, Arthritis and rheumatism.
[31] S. Chang,et al. Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese , 2003, Clinical Rheumatology.
[32] Luc J. Smink,et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.
[33] P. Gregersen,et al. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. , 2003, Arthritis and rheumatism.
[34] W. Thomson,et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.
[35] N. Wilkinson,et al. Disseminated congenital neuroblastoma presenting at birth , 2003, Archives of disease in childhood.
[36] Jacqueline K. White,et al. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. , 2003, Immunology letters.
[37] E. Zeggini,et al. Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. , 2002, Arthritis and rheumatism.
[38] D. Alarcón-Segovia,et al. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. , 2002, American journal of human genetics.
[39] P. Rieckmann,et al. CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis , 2002, Journal of Neuroimmunology.
[40] E. Zeggini,et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[41] Sampath Prahalad,et al. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[42] D. Lovell,et al. Advanced therapy for juvenile arthritis. , 2002, Best practice & research. Clinical rheumatology.
[43] C. Sanjeevi,et al. Major histocompatibility complex class I chain related (MIC) A gene, TNFa microsatellite alleles and TNFB alleles in juvenile idiopathic arthritis patients from Latvia. , 2002, Human immunology.
[44] P. Gregersen,et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.
[45] Ali Duzova,et al. Tumour necrosis factor α G→A −238 and G→A −308 polymorphisms in juvenile idiopathic arthritis , 2002 .
[46] S. Pearce,et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. , 2002, Rheumatology.
[47] J. Terwilliger,et al. Genomewide linkage analysis of celiac disease in Finnish families. , 2002, American journal of human genetics.
[48] J. Franklyn,et al. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. , 2002, Thyroid : official journal of the American Thyroid Association.
[49] A. Bakkaloğlu,et al. Tumour necrosis factor alpha G-->A -238 and G-->A -308 polymorphisms in juvenile idiopathic arthritis. , 2002, Rheumatology.
[50] S. Sawcer,et al. A genome screen for multiple sclerosis in Sardinian multiplex families , 2001, European Journal of Human Genetics.
[51] J. Barrett,et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis , 2001 .
[52] G. Assmann,et al. Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus. , 2001, Rheumatology.
[53] J. Barrett,et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group. , 2001, Arthritis and rheumatism.
[54] A. Demaine,et al. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[55] S D Thompson,et al. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. , 2000, Arthritis and rheumatism.
[56] A. Grom,et al. T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis , 2000, Current opinion in rheumatology.
[57] K. Tokunaga,et al. Independent contribution of HLA-DRB1 and TNFα promoter polymorphisms to the susceptibility to Crohn’s disease , 2000, Genes and Immunity.
[58] E. N. Miller,et al. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[59] W. Thomson,et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. , 2000, Tissue antigens.
[60] S. Pearce,et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. , 2000, Journal of hepatology.
[61] T. Olsson,et al. Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, Northern Italy, Sardinia and Sweden , 2000, Genes and Immunity.
[62] T. Sasazuki,et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. , 1999, Arthritis and rheumatism.
[63] D. Glass,et al. Juvenile rheumatoid arthritis as a complex genetic trait. , 1999, Arthritis and rheumatism.
[64] D. Glass,et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. , 1999, Arthritis and rheumatism.
[65] A. Silman,et al. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. , 1999, Human molecular genetics.
[66] J. Morrison,et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. , 1999, Human molecular genetics.
[67] J. Blackwell,et al. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility , 1999, Journal of medical genetics.
[68] J. Cloutier,et al. Cooperative Inhibition of T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase , 1999, The Journal of experimental medicine.
[69] FarhanA.J BarrettJ.H ThomsonW WorthingtonJ Ollier Wer. DonnR.P. Absence of association between interleukin 1 alpha and oligoarticular juvenile chronic arthritis in UK patients , 1999 .
[70] P. Gaffney,et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Petri,et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[72] N. Kamatani,et al. Identification of the gene loci that predispose to rheumatoid arthritis. , 1998, International immunology.
[73] Watson,et al. A cytotoxic T lymphocyte antigen‐4 (CTLA‐4) gene polymorphism is associated with autoimmune Addison's disease in English patients , 1998, Clinical endocrinology.
[74] J. Todd,et al. Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group. , 1998, Diabetes.
[75] M. Suarez‐Almazor,et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. , 1998, The Journal of rheumatology.
[76] J S Yudkin,et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.
[77] Barnett,et al. No evidence for allelic association of a human CTLA‐4 promoter polymorphism with autoimmune thyroid disease in either population‐based case–control or family‐based studies , 1998, Clinical endocrinology.
[78] G. Gyapay,et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. Trent,et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Bach,et al. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease , 1998, Gut.
[81] J. Weber,et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Cloutier,et al. Sequence Requirements for Association of Protein-tyrosine Phosphatase PEP with the Src Homology 3 Domain of Inhibitory Tyrosine Protein Kinase p50 csk * , 1998, The Journal of Biological Chemistry.
[83] K. Usadel,et al. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. , 1998, Tissue antigens.
[84] K. Usadel,et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. , 1997, The Journal of clinical endocrinology and metabolism.
[85] D. Mosier,et al. CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. , 1997, Journal of immunology.
[86] F. Pociot,et al. No association or linkage to IDDM of an interferon regulatory factor-1 gene polymorphism in a Danish population. The Danish Study Group for Diabetes in Childhood. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[87] S. Galandiuk,et al. The natural resistance-associated macrophage protein gene is associated with Crohn's disease. , 1997, Surgery.
[88] K. Kotsa,et al. A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism , 1997, Clinical endocrinology.
[89] R. Atkins,et al. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat , 1997, The Journal of experimental medicine.
[90] D. Glass,et al. Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy , 1996 .
[91] D. Clayton,et al. Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. , 1996, Journal of medical genetics.
[92] W. Ollier,et al. JUVENILE CHRONIC ARTHRITIS – A TIME FOR CHANGE? , 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[93] J. Blackwell,et al. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. , 1996, Molecular medicine today.
[94] E. Albert,et al. IMMUNOPRINTING EXCLUDES MANY POTENTIAL SUSCEPTIBILITY GENES AS PREDISPOSING TO EARLY ONSET PAUCIARTICULAR JUVENILE CHRONIC ARTHRITIS EXCEPT HLA CLASS II AND TNF , 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[95] C. Fink. Proposal for the development of classification criteria for idiopathic arthritides of childhood. , 1995, The Journal of rheumatology.
[96] P. Woo,et al. Inflammatory cytokine responses in juvenile chronic arthritis. , 1995, British journal of rheumatology.
[97] R. Płoski,et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism , 1995 .
[98] P. Liebmann,et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. , 1995, Arthritis and rheumatism.
[99] R. Płoski,et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. , 1995, Arthritis and rheumatism.
[100] T. Taniguchi,et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development , 1993, Cell.
[101] A. Martini,et al. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. , 1991, Arthritis and rheumatism.
[102] R. Petty,et al. Textbook of pediatric rheumatology , 1982 .
[103] J. Baum,et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. , 1977, Arthritis and rheumatism.